Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences

Article Stock Quotes (1)

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 9/1/2026

1. SPY
2. MDT
3. SPGI
4. USO
5. ENOV

6. AON
7. AZN
8. BLSM
9. A
10. GRMN

Get Alerts CNTA Hot Sheet

Price: $40.50 --0%

Overall Analyst Rating:
SELL (= Flat)

Join SI Premium – FREE

BOSTON and LONDON, May 24, 2023 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop transformational medicines for patients, today announced that members of its management team will participate in the following investor conferences:

Event: Jefferies Global Healthcare ConferenceDate: Friday, June 9, 2023Location: New York, NYFireside Chat: 10:30 AM ET

Event: Goldman Sachs 44th Annual Global Healthcare Conference Date: Tuesday, June 13, 2023Location: Dana Point, CAFireside Chat: 4:40 PM PT

Access to the live webcasts of these events, as well as archived recordings, will be available under the “Events and Publications” tab on the investor relations section of the Centessa Pharmaceuticals website at https://investors.centessa.com/events-presentations.

About Centessa Pharmaceuticals Centessa Pharmaceuticals plc is a clinical-stage pharmaceutical company that aims to discover and develop transformational medicines for patients. Our programs span discovery-stage to late-stage development and cover a range of high-value indications in rare diseases and immuno-oncology. We operate with the conviction that each one of our programs has the potential to change the current treatment paradigm and establish a new standard of care. For more information, visit www.centessa.com, which does not form part of this release.

Contact:Kristen K. Sheppard, Esq.SVP of Investor Relations[email protected]